Sanders-Brown Center on Aging, University of Kentucky, Lexington, Kentucky, United States of America.
Department of Neuroscience, University of Kentucky, Lexington, Kentucky, United States of America.
PLoS One. 2018 Apr 12;13(4):e0195765. doi: 10.1371/journal.pone.0195765. eCollection 2018.
Bilateral carotid artery stenosis (BCAS) is one experimental model of vascular dementia thought to preferentially impact brain white matter. Indeed, few studies report hippocampal and cortical pathology prior to 30 days post-stenosis; though it is unclear whether those studies examined regions outside the white matter. Since changes in the blood-brain barrier (BBB) permeability precede more overt brain pathology in various diseases, we hypothesized that changes within the BBB and/or BBB-associated extracellular matrix (ECM) could occur earlier after BCAS in the hippocampus, cortex and striatum and be a precursor of longer term pathology. Here, C57Bl/6 mice underwent BCAS or sham surgeries and changes in the BBB and ECM were analyzed by collagen IV (vascular basement membrane component), α5 integrin (marker of endothelial activation), claudin-5 and occludin (tight junction proteins), Evans blue (permeability marker), Ki-67 (cell proliferation marker), and GFAP and CD11b (glial cell markers) immunohistochemistry after 14 days. Significant changes in markers of cerebrovascular integrity and glial activation were detected, not only in the striatum, but also in the hippocampus and cortex. In conclusion, this study demonstrates for the first time that changes in the BBB/ECM occur shortly after BCAS and within multiple brain regions and suggests such changes might underlie the gradual development of BCAS non-white matter pathology.
双侧颈内动脉狭窄 (BCAS) 是血管性痴呆的一种实验模型,被认为优先影响脑白质。事实上,很少有研究报告在狭窄后 30 天之前出现海马和皮质病变;尽管尚不清楚这些研究是否检查了白质以外的区域。由于血脑屏障 (BBB) 通透性的变化先于各种疾病中更明显的脑部病理学变化,我们假设在 BCAS 后,BBB 内和/或 BBB 相关细胞外基质 (ECM) 的变化可能更早出现在海马体、皮质和纹状体,并成为更长期病理学的前兆。在这里,C57Bl/6 小鼠接受 BCAS 或假手术,通过胶原蛋白 IV(血管基底膜成分)、α5 整合素(内皮激活标志物)、紧密连接蛋白 claudin-5 和 occludin、伊文思蓝(通透性标志物)、Ki-67(细胞增殖标志物)和 GFAP 和 CD11b(神经胶质细胞标志物)免疫组织化学分析,在 14 天后分析 BBB 和 ECM 的变化。不仅在纹状体,而且在海马体和皮质中,都检测到了脑血管完整性和神经胶质激活标志物的显著变化。总之,这项研究首次表明,BCAS 后不久,BBB/ECM 就会发生变化,并且发生在多个脑区,这表明这种变化可能是 BCAS 非白质病理学逐渐发展的基础。